ResMed (RMD) Tops Q4 EPS by 2c, Beats on Revenues
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $229.19 -0.73%
Revenue Growth %: +9.2%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Revenue Growth %: +9.2%
Financial Fact:
Net income: 76.11M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $556.7 million versus the consensus estimate of $555.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
- Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
